Naschitz Brandes Amir serves as a strategic and advisory partner to all of the major players in the ever-evolving digital health industry, including medical providers and healthcare organizations, disruptive technology startups, established companies expanding into digital health, and investors involved in driving the healthcare market and its tremendous growth.
Our multi-disciplinary team of legal professionals helps clients with company formation, product development, patent prosecution and protection, venture financing, intellectual property transactions, data protection, privacy, and use and transmissions of data, M&A, IPO and securities law matters. We offer robust experience advising clients on a broad range of licensing, outsourcing, and other technology transactions with hospitals, physician groups, HMOs, health information networks, data partners, and technology companies.
Leveraging our in-depth industry knowledge and transaction experience, Naschitz Brandes Amir lawyers provide strategic guidance on how to identify growth opportunities, minimize legal risks, protect your intellectual property and realize its value.
How we help our clients:
- Venture Formation
- Technology Licensing
- Joint Ventures
- Clinically Integrated Networks
- Mergers and Acquisitions
- System Acquisition
- Saas and Paas Agreements
- Digital Asset Management
- IP Protection
- Advising on Professional and Cyber Liability Insurance
- Digital Health Contracting
- HIPAA Strategy
- Data Governance privacy and data protection
- Research agreements and secondary use of data
Healthy.io
Advised Healthy.io, a remote clinical testing company, on a number of its financing rounds as well as Healthy’s acquisition of its major US competitor, Inui Health.
dbMotion
Represented dbMotion, a connected healthcare company, in several investment rounds as well as its $420 million acquisition by Allscripts.
Leumit HMO
Advised Leumit HMO on a collaboration agreement with Sheba Medical Center for the establishment of a mutual R&D and digital health innovation center and commercialization of Leumit’s data and technologies.
MDClone
Advised MDClone, a healthcare data analysis startup, on a number of its financing rounds. We also counsel MDClone on various commercial agreements with Israeli medical centers and healthcare providers.
ION Crossover Partners
Advised ION Crossover Partners on its $75 million Round D investment in Happify Health.
DayTwo
Advised DayTwo, a precision medicine company, on a $37 million Series B investment round.
EyeControl
Advised EyeControl, an assistive communication technology startup on its $10 million funding round. We also represent the company in its ongoing corporate activity and privacy-related matters.
aMoon
Advised aMoon Fund on a number of matters including its investments in biotech and life sciences startups, including Aummune, MDClone, and Vocalis, and in its role as lead investor on a $55 million Series D equity financing in Seer.
CLEW Medical
Advised CLEW Medical, a clinical intelligence company on numerous commercial matters including all of its financing rounds.
Carebox Healthcare Solutions
Represented Carebox in a merger transaction with EmergingMed Clinical Trial Navigation Service.